Health

Sanofi and Alexandria Real Estate Equities could exit the chronic disease therapeutics developer, which has set the range for an offering that could raise up to $170m.

Illumina’s corporate venturing unit took part in a round that brought the proteomic platform developer’s overall funding to $110m.

Harvard spinout Emulate will use the cash to further develop its organ-on-a-chip technology, having now raised nearly $225m in total.

Q&A with William Taranto, president, Merck Global Health Innovation (GHI) Fund, and vice-president, Merck Global Health Innovation Group

Parkwalk Advisors and Cambridge Innovation Capital have backed the pet antibody therapeutics developer, a spinout of Wellcome Sanger Institute.

Stryker has bought the surgery monitoring software provider, which was backed by Stanford-StartX Fund.

Novo-backed surgical robot maker Procept will fund recruitment and product development initiatives with the proceeds of an IPO for which it has just set terms.

Existing backer Novo has helped the teeth straightening technology producer close a series D round hiking its overall funding to over $170m.

SR One Capital Management has led the RNA targeting drug developer’s latest round, participating alongside investors including Lilly Asia Ventures.

The Aviva and Foxconn-backed respiratory system developer beat the target for its series D round to bring its total funding to over $150m.

Alphabet subsidiary Verily is set to exit Ciitizen, a management software platform for healthcare data, after Invitae agreed to buy the company.